{"prompt": "['Placebo-Controlled Study-Tourette Syndrome', 'Clinical Study Protocol with Amendment 05', 'Study TV50717-CNS-30046', 'Protocol Amendment 01 text with', 'New wording', 'Reason/Justification', 'changes shown', 'for change', 'present before study entry and do not', 'worsen during this study will not be', 'considered adverse events.', '7.1.5 Serious Adverse Events', 'An additional blood sample for the', 'An additional blood sample for the', 'Additional text was', 'measurement of IMP concentration', 'measurement of IMP concentration', 'included to define', 'should be collected, if possible, from', 'should be collected, if possible, from', 'the period for', 'each patient experiencing a serious', 'each patient experiencing a serious', 'recording serious', 'adverse event or an adverse event', 'adverse event or an adverse event', 'adverse events', 'leading to discontinuation of IMP at', 'leading to discontinuation of IMP at', 'occurring in patients,', 'any time during the study. If study', 'any time during the study. If study', 'and to specify the', 'center personnel are unable to obtain a', 'center personnel are unable to obtain a', 'actions to be taken', 'blood sample in a timely fashion, this', 'blood sample in a timely fashion, this', 'by the investigator', 'should be discussed with the medical', 'should be discussed with the medical', 'should they become', 'monitor to determine whether the', 'monitor to determine whether the', 'aware of a serious', 'sample still needs to be obtained.', 'sample still needs to be obtained.', 'adverse event after', 'For recording of serious adverse', 'For recording of serious adverse', 'the end of the follow-', 'events, the study period is defined for', 'events, the study period is defined for', 'up period.', 'each patient as the time period from', 'each patient as the time period from', 'signature of the informed consent form', 'signature of the informed consent form', 'to the end of the follow up period, as', 'to the end of the follow up period, as', 'defined in Section 7.1.2. If the', 'defined in Section 7.1.2. If the', 'investigator becomes aware of serious', 'investigator becomes aware of serious', 'adverse events occurring in a patient', 'adverse events occurring in a patient', 'after the end of the follow up period,', 'after the end of the follow up period,', 'the serious adverse events should be', 'the serious adverse events should be', 'reported to the sponsor following the', 'reported to the sponsor following the', 'procedures described in Section', 'procedures described in Section', '7.1.5.3.1.', '7.1.5.3.1.', '7.1.5.1 Definition of a Serious Adverse Event', 'A serious adverse event is an adverse', 'A serious adverse event is an adverse', 'This was updated to', 'event occurring at any dose that results', 'event occurring at any dose that results', 'include the most', 'in any of the following outcomes or', 'in any of the following outcomes or', 'recent definition of a', 'actions:', 'actions:', 'serious adverse event', 'results in death', 'results in death', 'per Teva template', 'text.', 'is a life threatening adverse event', 'is a life threatening adverse event', '(ie, the patient was at immediate risk of', '(ie, the patient was at risk of death at', 'death from-at the time of the event as);', 'the time of the event); it does not refer', 'it occurred); does not include refer to', 'to an event which hypothetically might', 'an event that, had it occurred in a more', 'have caused death if it were more', 'severe form, which hypothetically', 'severe.', 'might have caused death if it were', 'requires inpatient hospitalization or', 'more severe.', 'prolongation of existing', 'requires inpatient hospitalization or', 'hospitalization, which means that', 'prolongation of existing', 'hospital inpatient admission or', '151']['Placebo-Controlled Study-Tourette Syndrome', 'Clinical Study Protocol with Amendment 05', 'Study TV50717-CNS-30046', 'Protocol Amendment 01 text with', 'New wording', 'Reason/Justification', 'changes shown', 'for change', 'hospitalization, which means that', 'prolongation of hospital stay were', 'hospital inpatient admission and/or', 'required for treatment of an adverse', 'prolongation of hospital stay were', 'event, or that they occurred as a', 'required for treatment of an adverse', 'consequence of the event.', 'event, or that they occurred as a', 'Hospitalizations scheduled before the', 'consequence of the event.', 'patient signed the informed consent', 'Hospitalizations scheduled prior to', 'form will not be considered serious', 'study entry before the patient signed', 'adverse events, unless there was', 'the informed consent form will not be', 'worsening of the preexisting condition', 'considered serious adverse events,', \"during the patient's participation in this\", 'unless there was worsening of the', 'study.', 'preexisting condition during the', 'results in persistent or significant', \"patient's participation in this study.\", 'disability or /incapacity (refers to a', 'results in persistent or significant', \"substantial disruption of one's ability to\", 'disability or /incapacity (refers to a', 'conduct normal life functions)', \"substantial disruption of one's ability to\", 'is a congenital anomaly/birth', 'conduct normal life functions)', 'defect', 'is a congenital anomaly/birth defect', 'an important medical event that', 'an important medical event that', 'may not result in death, be life', 'may not result in death, be life', 'threatening, or require hospitalization,', 'threatening, or require hospitalization,', 'but may jeopardize the patient and may', 'but may jeopardize the patient and may', 'require medical intervention to prevent', 'require medical intervention to prevent', 'one of the outcomes listed in this', 'one of the outcomes listed in this', 'definition.', 'definition.', 'Examples of such events are intensive', 'Examples of such events are intensive', 'treatment in an emergency room or at', 'treatment in an emergency room or at', 'home for allergic bronchospasm; blood', 'home for allergic bronchospasm; blood', 'dyscrasias or convulsions that do not', 'dyscrasias or convulsions that do not', 'result in hospitalization; or the', 'result in hospitalization; or the', 'development of drug dependency or', 'development of drug dependency or', 'drug abuse. Note: Any suspected', 'drug abuse. Note: Any suspected', 'transmission of an infectious agent via', 'transmission of an infectious agent via', 'a medicinal product is considered an', 'a medicinal product is considered an', 'important medical event.', 'important medical event.', '7.1.5.3.1 Investigator Responsibility', 'The investigator must ensure that the', 'Each report of a serious adverse event', 'Updates were made', 'IEC/IRB is also informed of the event,', 'will be reviewed and evaluated by the', 'to more clearly', 'in accordance with national and local', 'investigator and the sponsor to assess', 'indicate investigator', 'regulations.', 'the nature of the event and the', 'responsibilities and', 'Each report of a serious adverse event', 'relationship of the event to the IMP,', 'expectations.', 'will be reviewed and evaluated by the', 'study procedures, and to underlying', 'investigator and the sponsor to assess', 'disease.', 'the nature of the event and the', 'Additional information (follow up)', 'relationship of the event to the IMP,', 'about any serious adverse event', 'study procedures, and to underlying', 'unavailable at the initial reporting', '152']\n\n###\n\n", "completion": "END"}